Major investments secured by Dentognostics to help fight periodontal disease: © Dental Innovation Alliance
Dentognostics, a research-driven technology company seeking to improve patient outcomes against periodontal disease, has secured significant investment from the Dental Innovation Alliance (DIA) and Dental365. The new support helps its growth and innovation in the US dental market.
With its patented oral health and wellness products—including digital diagnostic readouts and PerioSafe mouthwash—Dentognostics continues to earn the trust and support of industry leaders. Pacific Dental Services (PDS) made a significant investment in 2021, partnering with Dentognostics to actively explore innovative technologies, including a tool to screen patients by taking a simple mouthwash sample, within their supported practices.
Dentognostics strives to empower patients with knowledge about what goes on in their mouths and to understand the importance of proper dental hygiene, periodontal care and maintenance. This is done with the company’s patented product that analyzes saliva to determine collagen-breaking activity in the mouth.
By providing patients with a quantitative oral fitness score, the company says the technology holds patients accountable for daily care behavior at home and allows the clinician to truly personalize patient care needs based on the data generated, ultimately building trust between of patients and dental care providers.
“Dentognostics’ support aligns perfectly with our mission at DIA, which is to advance innovation and collaboration in the fields of dentistry and healthcare,” says Thomas Sharpe, Managing Partner of DIA, in an Aug. 9 press release . “We strongly believe in the transformative power of Dentognostics technology and see it as a game changer in improving patient outcomes.”
DIA is a venture capital firm that finances, advises and helps early-stage dental technology companies succeed through its leadership and investment team, which has a combined experience of more than 200 years in the dental industry. Beyond capital, it provides guidance and connectivity designed to enhance sales activity for portfolio companies.
“Investing and providing other DIA resources to Dentognostics is a natural fit,” adds Doug Brown, DIA Managing Partner in the press release. “We believe in their technology and see potential in their trials to significantly improve patient outcomes. We are excited about its potential to revolutionize patient care and advance oral health worldwide.”
Scott Asnis, DDS, CEO of Dental365, a full-service dental group with locations throughout New York, Connecticut, New Jersey, New Hampshire, Massachusetts and Rhode Island, joined PDS and DIA as an investor .
“We sincerely thank Pacific Dental Services for their unwavering cooperation and support over the past 2 years. Their belief in our vision has been instrumental in our growth,” says Dirk-Rolf Gieselmann, founder and CEO of Dentognostics. “We are equally excited to welcome DIA and Dental365, whose investments further strengthen our position in the industry and affirm our commitment to 14 years of research and development. Together, we are poised to revolutionize the oral health landscape and reach to new heights.”
